Efficacy and safety of canakinumab as a second line biologic after tocilizumab treatment failure in children with systemic juvenile idiopathic arthritis: A single-centre cohort study using routinely collected health data
Ekaterina Alexeeva, Elizaveta Krekhova, Tatyana Dvoryakovskaya, Ksenia Isaeva, Aleksandra Chomakhidze, Evgeniya Chistyakova, Olga Lomakina, Rina Denisova, Anna Mamutova, Anna Fetisova, Marina Gautier, Dariya Vankova, Ivan Kriulin, Ruslan Saygitov
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 February 2023.
All research outputs
#18,900,960
of 23,420,064 outputs
Outputs from Frontiers in Pediatrics
#3,544
of 6,384 outputs
Outputs of similar age
#222,188
of 331,167 outputs
Outputs of similar age from Frontiers in Pediatrics
#153
of 309 outputs
Altmetric has tracked 23,420,064 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 6,384 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.6. This one is in the 31st percentile – i.e., 31% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 331,167 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 22nd percentile – i.e., 22% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 309 others from the same source and published within six weeks on either side of this one. This one is in the 38th percentile – i.e., 38% of its contemporaries scored the same or lower than it.
